OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current challenges in the treatment of cardiac fibrosis: Recent insights into the sex‐specific differences of glucose‐lowering therapies on the diabetic heart: IUPHAR Review 33
Abhipree Sharma, Miles J. De Blasio, Rebecca H. Ritchie
British Journal of Pharmacology (2022) Vol. 180, Iss. 22, pp. 2916-2933
Open Access | Times Cited: 11

Showing 11 citing articles:

Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies
Susana Ravassa, Begoña López, Thomas A. Treibel, et al.
Molecular Aspects of Medicine (2023) Vol. 93, pp. 101194-101194
Open Access | Times Cited: 36

Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis
Chang-E Yang, Yanni Wang, Meng-Ru Hua, et al.
Ageing Research Reviews (2022) Vol. 79, pp. 101662-101662
Closed Access | Times Cited: 14

A high-sucrose diet exacerbates the left ventricular phenotype in a high fat-fed streptozotocin rat model of diabetic cardiomyopathy
Anida Velagic, Mandy Li, Minh Deo, et al.
AJP Heart and Circulatory Physiology (2023) Vol. 324, Iss. 2, pp. H241-H257
Closed Access | Times Cited: 7

Therapeutic potential of relaxin or relaxin mimetics in managing cardiovascular complications of diabetes
Arun George Devasia, Meyammai Shanmugham, Adaikalavan Ramasamy, et al.
Biochemical Pharmacology (2024) Vol. 229, pp. 116507-116507
Closed Access | Times Cited: 2

Empagliflozin protects against isoprenaline-induced fibrosis in rat heart through modulation of TGF-β/SMAD pathway
Mohammed Elsayed, Yasser M. Moustafa, Eman T. Mehanna, et al.
Life Sciences (2023) Vol. 337, pp. 122354-122354
Closed Access | Times Cited: 5

YuNü-Jian attenuates diabetes-induced cardiomyopathy: integrating network pharmacology and experimental validation
Wei Wang, Ruixia Liu, Yingying Zhu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4

Therapeutic targets of fibrosis: Translational advances and current challenges
Miles J. De Blasio, Eliot H. Ohlstein, Rebecca H. Ritchie
British Journal of Pharmacology (2023) Vol. 180, Iss. 22, pp. 2839-2845
Open Access | Times Cited: 4

Exogenous ECM in an environmentally-mediatedin vitromodel for cardiac fibrosis
Natalie Pachter, Kristen E. Allen, Tracy A. Hookway
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1

Scroll to top